The Supreme Court will hear arguments Tuesday in a case involving a commonly used abortion pill, mifepristone, and the FDA’s recent actions to make it more accessible.
Lorem ipsum dolor sit amet, consectetur adipiscing elit. Ut elit tellus, luctus nec.